Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia

This phase I/II study was conducted to determine the maximum tolerated dose, toxicity, and efficacy of clofarabine in combination with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming (GCLAC), in the treatment of patients with relapsed or refractory acute myeloid leukae...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Haematol
Auteurs principaux: Becker, Pamela S., Kantarjian, Hagop M., Appelbaum, Frederick R., Petersdorf, Stephen H., Storer, Barry, Pierce, Sherry, Shan, Jianqin, Hendrie, Paul C., Pagel, John M., Shustov, Andrei R., Stirewalt, Derek L., Faderl, Stephan, Harrington, Elizabeth, Estey, Elihu H.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834701/
https://ncbi.nlm.nih.gov/pubmed/21848522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2011.08831.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires